Rx only · Injection, Solution · Subcutaneous

Alirocumab

Brands: Praluent · Alirocumab

2 ACTIVE SUPPLIERS - US

openFDA · updated weekly

US4 NDCs
2 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

RxCUI (US)1659152

US makers2 labelers

Packages10

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.

$257.878

Latest avg · Aug 19, 2026

+3%

Since Dec 17, 2025

Active US suppliers

Labeler	Type	Packages	Status
Regeneron Pharmaceuticals, Inc.	unknown	6	SUPPLYING
Sanofi-Aventis U.S. LLC	unknown	4	SUPPLYING